These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14154689)

  • 1. A NEW TEST FOR THE DIAGNOSIS OF GYNAECOLOGICAL CANCER, 6-PHOSPHOGLUCONATE DEHYDROGENASE ACTIVITY IN VAGINAL FLUID.
    BONHAM DG
    Triangle; 1964 Jan; 7():157-62. PubMed ID: 14154689
    [No Abstract]   [Full Text] [Related]  

  • 2. 6-PHOSPHOGLUCONATE DEHYDROGENASE ESTIMATION IN VAGINAL FLUID IN THE DIAGNOSIS OF CERVICAL CANCER.
    BELL JL; EGERTON ME
    J Obstet Gynaecol Br Commonw; 1965 Aug; 72():603-9. PubMed ID: 14341115
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE ACTIVITY OF PHOSPHO-6-GLUCONATE DEHYDROGENASE IN THE VAGINAL FLUID: NEW DIAGNOSTIC TEST FOR GENITAL CANCER].
    BONHAM DG
    Triangle; 1964 Jan; 7():157-62. PubMed ID: 14158437
    [No Abstract]   [Full Text] [Related]  

  • 4. A new enzyme test for gynaecological cancer. 6-Phosphogluconate dehydrogenase activity in vaginal fluid.
    BONHAM DG; GIBBS DF
    Br Med J; 1962 Sep; 2(5308):823-4. PubMed ID: 13870993
    [No Abstract]   [Full Text] [Related]  

  • 5. LABORATORY DIAGNOSIS OF EARLY MALIGNANT DISEASE. NEW DIAGNOSTIC TESTS FOR CANCER OF THE UTERUS.
    BONHAM DG
    Trans Med Soc Lond; 1964; 80():30-41. PubMed ID: 14270933
    [No Abstract]   [Full Text] [Related]  

  • 6. 6-PHOSPHOGLUCONATE DEHYDROGENASE ACTIVITY IN VAGINAL FLUID: LIMITATIONS AS A SCREENING TEST FOR GENITAL CANCER.
    CAMERON CB; HUSAIN OA
    Br Med J; 1965 Jun; 1(5449):1529-30. PubMed ID: 14288104
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the use of enzyme tests and electronic particle sizing as a screening method for gynaecological cancer.
    Wootton ID; Sheppered Y; Campbell N
    J Obstet Gynaecol Br Commonw; 1967 Apr; 74(2):275-8. PubMed ID: 6022379
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of blood on the assay of 6-phosphogluconate dehydrogenase in vaginal fluid.
    Gibbs DF
    J Clin Pathol; 1968 Mar; 21(2):189-91. PubMed ID: 4235156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-phosphogluconate dehydrogenase (6PGD) activity in the cervical mucus and vaginal fluid in benign and malignant gynaecological lesions.
    Brooks PC; Muir GG
    J Obstet Gynaecol Br Commonw; 1967 Feb; 74(1):111-4. PubMed ID: 6018084
    [No Abstract]   [Full Text] [Related]  

  • 10. Carcinoma of the cervix. Automated methods for cancer screening.
    Husain OA; Cameron CB
    Proc R Soc Med; 1966 Oct; 59(10):982-6. PubMed ID: 5955773
    [No Abstract]   [Full Text] [Related]  

  • 11. [STUDIES ON THE SIGNIFICANCE OF ENZYME TESTS (GLUCOSE-6-PHOSPHATE-DEHYDROGENASE AND 6-PHOSPHOGLUCONATE-DEHYDROGENASE) FOR THE EARLY DETECTION OF GYNECOLOGICAL CANCER DISEASES].
    VORHERR H; TRAEGER L; HUETER J; BRANDT H
    Arch Gynakol; 1965 Apr; 200():384-92. PubMed ID: 14343459
    [No Abstract]   [Full Text] [Related]  

  • 12. THE ACTIVITY OF 6-PHOSPHOGLUCONIC ACID DEHYDROGENASE IN VAGINAL SECRETIONS. A COMPARATIVE STUDY OF THE ACTIVITY IN WOMEN WITH AND WITHOUT GYNECOLOGICAL CANCER.
    NERDRUM HJ
    Scand J Clin Lab Invest; 1964; 16():565-9. PubMed ID: 14209218
    [No Abstract]   [Full Text] [Related]  

  • 13. A modified assay for 6-phosphogluconate dehydrogenase in samples of vaginal fluid from women with and without gynecologic cancer.
    Rees KR; Slater TF; Gibbs DF; Stagg BH
    Am J Obstet Gynecol; 1970 Jul; 107(6):857-64. PubMed ID: 5429014
    [No Abstract]   [Full Text] [Related]  

  • 14. 6-PHOSPHOGLUCONATE DEHYDROGENASE IN UTERINE CANCER DETECTION.
    HOFFMAN RL; MERRITT JW
    Am J Obstet Gynecol; 1965 Jul; 92():650-7. PubMed ID: 14308735
    [No Abstract]   [Full Text] [Related]  

  • 15. Cervical screening for carcinoma: a comparison of cytological and enzyme (6-phosphogluconate dehydrogenase) methods and clinical findings.
    Boyd JT; Gibbs DF; Labrum AH; Philps FR
    Br Med J; 1967 Jun; 2(5555):785-92. PubMed ID: 6029138
    [No Abstract]   [Full Text] [Related]  

  • 16. ACCURACY OF CYTOLOGIC DIAGNOSIS IN THE TREATED CANCER.
    GRAHAM RM
    Acta Cytol; 1964; 8():3-10. PubMed ID: 14110624
    [No Abstract]   [Full Text] [Related]  

  • 17. [Is a diagnosis of genital carcinomas by determination of the 6-phosphogluconate dehydrogenase activity of vaginal secretion possible?].
    Jütting G; Kuss E; Martius G
    Klin Wochenschr; 1965 Oct; 43(19):1057-60. PubMed ID: 5881531
    [No Abstract]   [Full Text] [Related]  

  • 18. ENZYMES AND MALIGNANCY.
    BEACONSFIELD P; GINGBURG J
    Lancet; 1965 Feb; 1(7380):324. PubMed ID: 14252315
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for cervical cancer.
    Br Med J; 1967 Jun; 2(5555):782-3. PubMed ID: 6029136
    [No Abstract]   [Full Text] [Related]  

  • 20. The early diagnosis of carcinoma of the female genital tract. II. Vaginal fluid 6-phosphogluconate dehydrogenase activity as a test for carcinoma of the cervix.
    Moukter M; Higgins G
    J Obstet Gynaecol Br Commonw; 1965 Oct; 72(5):684-90. PubMed ID: 5891592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.